Poggio, E.* ; Barazzuol, L.* ; Salmaso, A.* ; Milani, C.* ; Deligiannopoulou, A.* ; Cazorla, Á.G.* ; Jang, S.S.* ; Juliá-Palacios, N.* ; Keren, B.* ; Kopajtich, R. ; Lynch, S.A.* ; Mignot, C.* ; Moorwood, C.* ; Neuhofer, C. ; Nigro, V.* ; Oostra, A.* ; Prokisch, H. ; Saillour, V.* ; Schuermans, N.* ; Torella, A.* ; Verloo, P.* ; Yazbeck, E.* ; Zollino, M.* ; Jech, R.* ; Winkelmann, J. ; Necpál, J.* ; Calì, T.* ; Brini, M.* ; Zech, M.
ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures.
Genet. Med. 25:100971 (2023)
Purpose: ATP2B2 encodes the variant-constrained plasma-membrane calcium-transporting ATPase-2, expressed in sensory ear cells and specialized neurons. ATP2B2/Atp2b2 variants were previously linked to isolated hearing loss in patients and neurodevelopmental deficits with ataxia in mice. We aimed to establish the association between ATP2B2 and human neurological disorders. Methods: Multinational case recruitment, scrutiny of trio-based genomics data, in silico analyses, and functional variant characterization were performed. Results: We assembled 7 individuals harboring rare, predicted deleterious heterozygous ATP2B2 variants. The alleles comprised 5 missense substitutions that affected evolutionarily conserved sites and 2 frameshift variants in the penultimate exon. For 6 variants, a de novo status was confirmed. Unlike described patients with hearing loss, the individuals displayed a spectrum of neurological abnormalities, ranging from ataxia with dystonic features to complex neurodevelopmental manifestations with intellectual disability, autism, and seizures. Two cases with recurrent amino-acid variation showed distinctive overlap with cerebellar atrophy-associated ataxia and epilepsy. In cell-based studies, all variants caused significant alterations in cytosolic calcium handling with both loss- and gain-of-function effects. Conclusion: Presentations in our series recapitulate key phenotypic aspects of Atp2b2-mouse models and underline the importance of precise calcium regulation for neurodevelopment and cerebellar function. Our study documents a role for ATP2B2 variants in causing heterogeneous neurodevelopmental and movement-disorder syndromes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Ataxia ; Atp2b2 ; Dystonia ; Neurodevelopmental Disorder ; Plasma Membrane Ca Atpase Isoform 2 2+; Plasma-membrane Ca2+-atpase; Pump; Mutation; Pathogenicity
Keywords plus
Language
english
Publication Year
2023
Prepublished in Year
0
HGF-reported in Year
2023
ISSN (print) / ISBN
1530-0366
e-ISSN
1098-3600
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 25,
Issue: 12,
Pages: ,
Article Number: 100971
Supplement: ,
Series
Publisher
Lippincott Williams & Wilkins
Publishing Place
Baltimore, Md.
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30205 - Bioengineering and Digital Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-503200-001
G-503292-001
Grants
Copyright
Erfassungsdatum
2023-10-18